nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ABCC1—Rifampicin—leprosy	0.532	0.548	CbGbCtD
Vemurafenib—CYP1A2—Thalidomide—leprosy	0.151	0.156	CbGbCtD
Vemurafenib—CYP1A2—Rifampicin—leprosy	0.147	0.151	CbGbCtD
Vemurafenib—CYP3A4—Rifampicin—leprosy	0.0769	0.0792	CbGbCtD
Vemurafenib—CYP3A4—Dapsone—leprosy	0.0634	0.0654	CbGbCtD
Vemurafenib—Erythema nodosum—Thalidomide—leprosy	0.00237	0.0789	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Dapsone—leprosy	0.00115	0.0382	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Dapsone—leprosy	0.0011	0.0366	CcSEcCtD
Vemurafenib—Rash maculo-papular—Thalidomide—leprosy	0.000931	0.031	CcSEcCtD
Vemurafenib—Erythema—Dapsone—leprosy	0.000875	0.0291	CcSEcCtD
Vemurafenib—Photosensitivity—Thalidomide—leprosy	0.000847	0.0282	CcSEcCtD
Vemurafenib—Atrial fibrillation—Thalidomide—leprosy	0.000785	0.0261	CcSEcCtD
Vemurafenib—Arthritis—Thalidomide—leprosy	0.000765	0.0255	CcSEcCtD
Vemurafenib—Cough—Dapsone—leprosy	0.000764	0.0254	CcSEcCtD
Vemurafenib—Pain in extremity—Thalidomide—leprosy	0.000744	0.0248	CcSEcCtD
Vemurafenib—Dry skin—Thalidomide—leprosy	0.000682	0.0227	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00067	0.0223	CcSEcCtD
Vemurafenib—Eosinophilia—Thalidomide—leprosy	0.000637	0.0212	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Thalidomide—leprosy	0.000587	0.0195	CcSEcCtD
Vemurafenib—Weight decreased—Thalidomide—leprosy	0.000582	0.0194	CcSEcCtD
Vemurafenib—Infestation NOS—Thalidomide—leprosy	0.000573	0.0191	CcSEcCtD
Vemurafenib—Infestation—Thalidomide—leprosy	0.000573	0.0191	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000568	0.0189	CcSEcCtD
Vemurafenib—Body temperature increased—Dapsone—leprosy	0.000565	0.0188	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Thalidomide—leprosy	0.000562	0.0187	CcSEcCtD
Vemurafenib—Oedema peripheral—Thalidomide—leprosy	0.000507	0.0169	CcSEcCtD
Vemurafenib—Erythema multiforme—Thalidomide—leprosy	0.000487	0.0162	CcSEcCtD
Vemurafenib—Eye disorder—Thalidomide—leprosy	0.000481	0.016	CcSEcCtD
Vemurafenib—Cardiac disorder—Thalidomide—leprosy	0.000478	0.0159	CcSEcCtD
Vemurafenib—Angiopathy—Thalidomide—leprosy	0.000467	0.0156	CcSEcCtD
Vemurafenib—Mediastinal disorder—Thalidomide—leprosy	0.000464	0.0154	CcSEcCtD
Vemurafenib—Chills—Thalidomide—leprosy	0.000462	0.0154	CcSEcCtD
Vemurafenib—Alopecia—Thalidomide—leprosy	0.000455	0.0151	CcSEcCtD
Vemurafenib—Vomiting—Dapsone—leprosy	0.000454	0.0151	CcSEcCtD
Vemurafenib—Malnutrition—Thalidomide—leprosy	0.000448	0.0149	CcSEcCtD
Vemurafenib—Headache—Dapsone—leprosy	0.000447	0.0149	CcSEcCtD
Vemurafenib—Dysgeusia—Thalidomide—leprosy	0.000439	0.0146	CcSEcCtD
Vemurafenib—Back pain—Thalidomide—leprosy	0.000433	0.0144	CcSEcCtD
Vemurafenib—Nausea—Dapsone—leprosy	0.000424	0.0141	CcSEcCtD
Vemurafenib—Cough—Thalidomide—leprosy	0.000391	0.013	CcSEcCtD
Vemurafenib—Myalgia—Thalidomide—leprosy	0.000381	0.0127	CcSEcCtD
Vemurafenib—Arthralgia—Thalidomide—leprosy	0.000381	0.0127	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000379	0.0126	CcSEcCtD
Vemurafenib—Infection—Thalidomide—leprosy	0.000363	0.0121	CcSEcCtD
Vemurafenib—Nervous system disorder—Thalidomide—leprosy	0.000359	0.0119	CcSEcCtD
Vemurafenib—Skin disorder—Thalidomide—leprosy	0.000355	0.0118	CcSEcCtD
Vemurafenib—Hypotension—Thalidomide—leprosy	0.000342	0.0114	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Thalidomide—leprosy	0.000333	0.0111	CcSEcCtD
Vemurafenib—Decreased appetite—Thalidomide—leprosy	0.000318	0.0106	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Thalidomide—leprosy	0.000316	0.0105	CcSEcCtD
Vemurafenib—Fatigue—Thalidomide—leprosy	0.000315	0.0105	CcSEcCtD
Vemurafenib—Constipation—Thalidomide—leprosy	0.000313	0.0104	CcSEcCtD
Vemurafenib—Body temperature increased—Thalidomide—leprosy	0.000289	0.00963	CcSEcCtD
Vemurafenib—Hypersensitivity—Thalidomide—leprosy	0.000269	0.00897	CcSEcCtD
Vemurafenib—Asthenia—Thalidomide—leprosy	0.000262	0.00874	CcSEcCtD
Vemurafenib—Pruritus—Thalidomide—leprosy	0.000259	0.00862	CcSEcCtD
Vemurafenib—Diarrhoea—Thalidomide—leprosy	0.00025	0.00833	CcSEcCtD
Vemurafenib—Dizziness—Thalidomide—leprosy	0.000242	0.00805	CcSEcCtD
Vemurafenib—Vomiting—Thalidomide—leprosy	0.000232	0.00774	CcSEcCtD
Vemurafenib—Rash—Thalidomide—leprosy	0.000231	0.00768	CcSEcCtD
Vemurafenib—Dermatitis—Thalidomide—leprosy	0.00023	0.00767	CcSEcCtD
Vemurafenib—Headache—Thalidomide—leprosy	0.000229	0.00763	CcSEcCtD
Vemurafenib—Nausea—Thalidomide—leprosy	0.000217	0.00723	CcSEcCtD
